Navigation Links
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers
Date:1/27/2009

Test may help physicians identify effective treatment earlier

MALVERN, Pa. and Abbott Park, Ill., Jan. 27 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to develop a new ovarian cancer test for use on Abbott's automated ARCHITECT(R) diagnostic analyzers. Under the agreement, Fujirebio Diagnostics will develop and manufacture for Abbott the HE4 biomarker, a simple blood test that may help in the risk stratification of women at high risk for ovarian cancer, a difficult disease to detect in its early stage.

"While the medical industry has familiarized the public with warning signs and symptoms of ovarian cancer, the key to combating this lethal disease is better detection tools and technologies," said Olle Nilsson, Ph.D., vice president and chief scientific officer, Fujirebio Diagnostics. "The HE4 test, which is expected to be available in 2009, will allow Abbott, on the ARCHITECT system, to provide clinicians worldwide with a tool to help define a pelvic mass so that appropriate treatment can be best identified earlier and more effectively."

HE4 in a manual format is currently FDA-cleared for monitoring recurrent or progressive disease in patients with epithelial ovarian cancer (EOC), and CE-marked in Europe as an aid in estimating the risk of EOC in premenopausal or postmenopausal women presenting with a pelvic mass. The HE4 manual test and corresponding Risk of Ovarian Malignancy Algorithm (ROMA(TM)) are pending clearance by the United States Food and Drug Administration (FDA) for use in women who present with a pelvic mass.

"More than 250,000 women present to their physician each year with a suspicious pelvic mass, yet there is still no reliable tool to differentiate malignant disease from other benign gynecologic conditions," said Robert Doss, Ph.D., divisional vice president, research and development, Abbott Diagnostics. "HE4 represents an impo
'/>"/>

SOURCE Fujirebio Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
2. Quest Diagnostics Reports Growth in Revenue and Earnings for Fourth Quarter 2008 and Provides 2009 Guidance
3. Quest Diagnostics Board Authorizes $500 Million in Share Repurchases
4. Alpine Biomed Acquires Stellate to Create New Leader in Neurology Diagnostics Market
5. Pathwork Diagnostics Launches Version of Its Tissue of Origin Test for FFPE Specimens
6. Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results
7. HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor
8. Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc.
9. Development of Novel Assays Vital for the European Immunoassay Diagnostics Market
10. Pathwork Diagnostics Collaborates With Guys and St Thomas on Tissue of Origin Test Validation in the UK
11. Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... and Bioengineering will host its second Edward C. Nagy ... NIH campus. There will be ten exciting presentations from ... research. , WHO: , ... Voltage Sensor, Quyen Nguyen, Univ. of California, San ... Imaging during Surgery, Jan Grimm, Memorial ...
(Date:7/23/2014)... Thousands of DePuy Pinnacle hip lawsuits ... federal multidistrict litigation underway in U.S. District Court, Northern ... an Order dated July 18th, U.S. District Judge Ed ... a $1,000 fee for the preservation and return of ... things, the Order noted that there is no evidence ...
(Date:7/23/2014)... 2014 The voice on the recording was low ... the news he was infected with the human immunodeficiency virus (HIV) ... and next thing you know I was on the floor flat ... message was hopeful when the recording ended less than 10 minutes ... . . because it is just God setting you up ...
(Date:7/23/2014)... 2014 (HealthDay News) --,Jealousy may not be the sole ... get downright possessive when it comes to the love ... toward what was actually a stuffed dog, the real ... the stuffed dog aside, report researchers from the University ... only surfaced when owners were attending to the stuffed ...
(Date:7/23/2014)... is a disease of the genome resulting from a ... our parents strong or weak predispositions to developing certain ... mutations in our cells throughout our lifetime. Although the ... long time, researchers were not able to measure the ... A team of geneticists from the University of Geneva ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:Dogs Can Get Jealous, Too 2Health News:Genetics of cancer: Non-coding DNA can finally be decoded 2
... Uncovering some science behind the type of intuition known as ... that a woman can tell whether a man is straight ... ovulating. Women also appear to have a heightened sensitivity ... romantic notions or mating aspirations, the new study revealed. ...
... Rochelle, NY, June 27, 2011The nature of cell phone ... the quality of their relationship, and much depends on ... of the conversation, according to an illuminating study reported ... a peer-reviewed journal published by Mary Ann Liebert, Inc. ...
... characterised by heroes and masculinity. This image is commonly ... in the firemen calendars produced by the firefighters themselves. ... profession make efforts to maintain and take advantage of ... Mathias Ericson, the author of a doctoral thesis based ...
... Pryor, M.D., president and CEO of Scott & White Healthcare, ... 65 nationally to be named to Becker,s Hospital Review annual ... their array of experience in medicine and management, these men ... health care industry. According to Becker,s, physician ...
... HealthDay Reporter , SATURDAY, June 25 (HealthDay News) ... in life expectancy between people with type 1 diabetes and ... expectancy at birth for someone diagnosed with type 1 diabetes ... compared to 72.4 years for the general population. But, for ...
... most prevalent illicit drug used by teenagers and adults around ... the United States report smoking it, and most high schoolers ... many people, smoking pot is no big deal. They cite ... is doing it." Denise Walker, co-director of the University ...
Cached Medicine News:Health News:Ovulation Seems to Aid Women's 'Gaydar' 2Health News:Firefighters are no macho men 2Health News:Life Expectancy Improves for Type 1 Diabetics 2Health News:Life Expectancy Improves for Type 1 Diabetics 3Health News:2 talks with teens leads to less marijuana use for at least a year 2Health News:2 talks with teens leads to less marijuana use for at least a year 3
(Date:7/23/2014)... 2014  Nearly 8,000 attendees will converge in ... Retail Business Conference (RBC), taking place July 23-26 at ... event encourages pharmacists to "Lead Change" in the pharmacy ... for their future. "RBC is the ... their peers and learn new ways they can lead ...
(Date:7/23/2014)... CITY, Calif. , July 23, 2014  Cardica, Inc. ... release financial results for its fiscal fourth quarter and year ... the markets close. Cardica,s management will host a conference call ... and provide an update on the company,s business. ... August 7, 2014, at 4:30 p.m. Eastern Time via phone, ...
(Date:7/23/2014)... NEW YORK , July 23, 2014  Dompe, a ... of rare diseases, announces that rhNGF (Recombinant Human Nerve Growth ... American Food and Drug Administration (FDA). The ... designated as an orphan drug for the treatment of neurotrophic ... in 5,000 people 1 and is currently without a ...
Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4
... 28, 2011 Streamline Health Solutions, Inc. (Nasdaq: ... workflow solutions for hospitals, announced today that two of ... system in North Carolina, contracted with Streamline Health to ... Resources, which began the beta phase of integration earlier ...
... Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical ... quarter ended June 30, 2011 will be released before the ... team will host a conference call to discuss the company,s ... 11, 2011 at 9 a.m. ET. The call can be ...
Cached Medicine Technology:Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 2Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 3Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 4Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call 2
... Pump™ is a quiet, compact, efficient vacuum ... The oil-free design and TEFLON®/ETFE coated vapor ... reliability and reduced maintenance. Unique features include ... protection, and a 1-liter post-pump solvent recovery ...
Produces vacuum pressures required for 96 well kits...
... DirectPrep 96 plates and MinElute 96 ... sample handling and accelerated processing; ... plates and MinElute 96 UF PCR ... of internal components by simply separating ...
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Medicine Products: